Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

AAquestive Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
A

Aquestive Therapeutics, Inc.

$4.95Close · Sep 22, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $13.82M. Net result −$22.86M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $13.82M. Running result $13.82M. Co Development And Research Fees: $582K. License And Royalty Revenue: $1.33M. Manufacture And Supply Revenue: $11.91M. Proprietary Product Revenue: $0.
  • Cost of revenue: −$4.02M. Running result $9.8M.
  • Gross profit: $9.8M. Running result $9.8M.
  • Research and development: −$3.96M. Running result $5.84M.
  • Selling, general and administrative: −$14.06M. Running result −$8.22M.
  • Operating income: −$8.22M. Running result −$8.22M.
  • Other expense: −$14.64M. Running result −$22.86M.
  • Pre-tax loss: −$22.86M. Running result −$22.86M.
  • Income tax benefit: $0. Running result −$22.86M.
  • Net loss: −$22.86M. Running result −$22.86M.